Corticosteroids for Guillain‐Barré syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corticosteroids for Guillain‐Barré Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438157/all/Corticosteroids_for_Guillain‐Barré_syndrome.
Corticosteroids for Guillain‐Barré syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438157/all/Corticosteroids_for_Guillain‐Barré_syndrome. Accessed November 22, 2024.
Corticosteroids for Guillain‐Barré syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438157/all/Corticosteroids_for_Guillain‐Barré_syndrome
Corticosteroids for Guillain‐Barré Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438157/all/Corticosteroids_for_Guillain‐Barré_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corticosteroids for Guillain‐Barré syndrome
ID - 438157
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438157/all/Corticosteroids_for_Guillain‐Barré_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -